Neurological Disorders

Neurological disorder research demands proteins that capture the complexity of the nervous system and its interactions with systemic biology. Athens proteins are purified from native human sources to preserve the structure and activity your experiments require.

Our neurological biomarkers and research reagents have supported published work on neurogenesis, Alzheimer's diagnostics, and oxidative stress – reflecting the breadth of applications these proteins enable.

What sets Athens apart for neurological research:

Apolipoproteins for neurodegeneration studies – ApoE and other apolipoproteins implicated in Alzheimer's disease risk, lipid metabolism in the CNS, and blood-brain barrier function.

Antioxidant enzymes – Superoxide Dismutase (SOD) and Catalase for oxidative stress research, including studies of ALS, Parkinson's, and other neurodegenerative conditions.

Cholinesterases – Butyrylcholinesterase (BChE) for Alzheimer's research and diagnostic development, with native enzymatic activity preserved.

Transport proteins linked to neurological disease – Transthyretin (prealbumin) for amyloidosis research, Ceruloplasmin for copper metabolism and Wilson's disease, and Hemopexin for heme regulation and neurogenesis studies.

Lipoproteins including oxidized LDL – For research on neuroinflammation, vascular contributions to cognitive impairment, and lipid-mediated neurotoxicity.